Discussion stirs around Cardiovascular Systems Inc (NASDAQ:CSII) this week; here is what analysts are saying.

June 20, 2017 - By Migdalia James

 Discussion stirs around Cardiovascular Systems Inc (NASDAQ:CSII) this week; here is what analysts are saying.
Investors sentiment decreased to 1.31 in 2016 Q4. Its down 0.46, from 1.77 in 2016Q3. It dived, as 16 investors sold Cardiovascular Systems Inc shares while 38 reduced holdings. 23 funds opened positions while 48 raised stakes. 23.59 million shares or 1.83% more from 23.16 million shares in 2016Q3 were reported.
Fifth Third Commercial Bank invested in 0% or 2,492 shares. Eam Invsts Limited holds 0.42% in Cardiovascular Systems Inc (NASDAQ:CSII) or 129,963 shares. Royal Bancorp Of Canada reported 19,275 shares stake. Invesco Limited stated it has 254,581 shares or 0% of all its holdings. 33,638 were accumulated by Credit Suisse Ag. 23,721 are owned by Jane Street Grp. United Service Automobile Association has invested 0.01% in Cardiovascular Systems Inc (NASDAQ:CSII). Frontier Mngmt Co Limited reported 844,049 shares stake. Us Bancorporation De stated it has 0% of its portfolio in Cardiovascular Systems Inc (NASDAQ:CSII). Parametric Portfolio Assoc Lc reported 26,600 shares. Citadel Advsr Ltd Llc holds 587,006 shares or 0.01% of its portfolio. Gsa Cap Llp holds 0.03% of its portfolio in Cardiovascular Systems Inc (NASDAQ:CSII) for 18,022 shares. Menta Capital Ltd Liability Company owns 27,570 shares for 0.06% of their portfolio. Neuberger Berman Group Lc has 0% invested in Cardiovascular Systems Inc (NASDAQ:CSII). Jpmorgan Chase And Company invested in 0% or 169,103 shares.

Cardiovascular Systems Inc (NASDAQ:CSII) Ratings Coverage

Among 7 analysts covering Cardiovascular Systems (NASDAQ:CSII), 5 have Buy rating, 1 Sell and 1 Hold. Therefore 71% are positive. Cardiovascular Systems had 17 analyst reports since August 6, 2015 according to SRatingsIntel. As per Thursday, September 3, the company rating was downgraded by Zacks. The firm has “Buy” rating by Needham given on Thursday, November 5. The rating was upgraded by Leerink Swann on Monday, August 22 to “Outperform”. Bank of America upgraded Cardiovascular Systems Inc (NASDAQ:CSII) on Thursday, August 4 to “Neutral” rating. The stock of Cardiovascular Systems Inc (NASDAQ:CSII) has “Sell” rating given on Friday, August 21 by Zacks. Dougherty & Company maintained the shares of CSII in report on Thursday, October 8 with “Buy” rating. The firm has “Hold” rating by Zacks given on Monday, August 10. Leerink Swann downgraded Cardiovascular Systems Inc (NASDAQ:CSII) on Thursday, October 8 to “Market Perform” rating. On Friday, April 1 the stock rating was upgraded by Needham to “Buy”. The firm has “Underperform” rating by Bank of America given on Thursday, October 8. Below is a list of Cardiovascular Systems Inc (NASDAQ:CSII) latest ratings and price target changes.

30/01/2017 Broker: Lake Street Rating: Buy New Target: $40 Initiate
26/01/2017 Broker: Needham Rating: Buy Old Target: $27.0 New Target: $32.0 Maintain

The stock increased 2.80% or $0.87 during the last trading session, reaching $31.96. About shares traded. Cardiovascular Systems Inc (NASDAQ:CSII) has risen 113.78% since June 20, 2016 and is uptrending. It has outperformed by 97.08% the S&P500.

Cardiovascular Systems, Inc. is a medical technology company. The company has market cap of $1.04 billion. The Firm is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. It currently has negative earnings. The Firm develops an orbital atherectomy technology for both peripheral and coronary commercial applications.

More notable recent Cardiovascular Systems Inc (NASDAQ:CSII) news were published by: Nasdaq.com which released: “Commit To Purchase Cardiovascular Systems At $25, Earn 9.2% Annualized Using …” on June 08, 2017, also Startribune.com with their article: “Former Cardiovascular Systems Inc. employee awarded $25 million in …” published on April 26, 2017, Nasdaq.com published: “Cardiovascular Systems Innovation On Track, Competition Rife” on June 07, 2017. More interesting news about Cardiovascular Systems Inc (NASDAQ:CSII) were released by: Nasdaq.com and their article: “Cardiovascular Systems (CSII) Hits 52-Week High on Solid Q3” published on June 12, 2017 as well as Startribune.com‘s news article titled: “Judge dismisses shareholder lawsuit against Cardiovascular Systems” with publication date: March 31, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.